Longitudinal data on humoral response and neutralizing antibodies against SARS-CoV-2 Omicron BA.1 and subvariants BA.4/5 and BQ.1.1 after COVID-19 vaccination in cancer patients

PURPOSE: The SARS-CoV-2 Omicron variant of concern (VOC) and subvariants like BQ.1.1 demonstrate immune evasive potential. Little is known about the efficacy of booster vaccinations regarding this VOC and subvariants in cancer patients. This study is among the first to provide data on neutralizing a...

Descripción completa

Detalles Bibliográficos
Autores principales: Overheu, Oliver, Lendowski, Simon, Quast, Daniel R., Kühn, Daniel, Vidal Blanco, Elena, Kraeft, Anna-Lena, Steinmann, Eike, Kourti, Eleni, Lugnier, Celine, Steinmann, Joerg, Reinacher-Schick, Anke, Pfaender, Stephanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257184/
https://www.ncbi.nlm.nih.gov/pubmed/37300723
http://dx.doi.org/10.1007/s00432-023-04961-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257184/
https://www.ncbi.nlm.nih.gov/pubmed/37300723
http://dx.doi.org/10.1007/s00432-023-04961-2

Ejemplares similares